UPDATE 1-Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports

Reuters10-04 21:25

(Adds details from the report in paragraphs 3 and 4)

Oct 4 (Reuters) - GSK , Sanofi and CSL Ltd have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, Bloomberg News reported on Friday.

The move comes as a multi-state outbreak among livestock and poultry has caused several human infections, raising concerns about further spread.

The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising the country's total supply of ready-to-use doses to 10 million within the first quarter of 2025, Dawn O'Connell, assistant secretary for preparedness and response at the U.S. Department of Health and Human Services told Bloomberg News.

The latest award from the government, which includes $37.9 million for CSL, $23.4 million for Sanofi and $10.5 million for GSK, would more than double the United States' supply of shots targeting bird flu, the report added.

The Department of Health and Human Services, Sanofi, CSL and GSK did not immediately respond to a Reuters request for comment.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas)

((Sriparna.Roy@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2472895499?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-04 21:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472895499","market":null,"top_or_hot":-1,"title":"UPDATE 1-Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports","media":"Reuters","content":"<html><body><p>(Adds details from the report in paragraphs 3 and 4)</p><p>      Oct 4 (Reuters) - GSK   , <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and CSL Ltd    have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, Bloomberg News reported on Friday.</p><p>       The move comes as a multi-state outbreak among livestock and poultry has caused several human infections, raising concerns about further spread.</p><p>   The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising the country's total supply of ready-to-use doses to 10 million within the first quarter of 2025, Dawn O'Connell, assistant secretary for preparedness and response at the U.S. Department of Health and Human Services told Bloomberg News.</p><p>       The latest award from the government, which includes $37.9 million for CSL, $23.4 million for <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> and $10.5 million for GSK, would more than double the United States' supply of shots targeting bird flu, the report added.</p><p>       The Department of Health and Human Services, Sanofi, CSL and GSK did not immediately respond to a Reuters request for comment.</p><p> (Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas)</p><p>((Sriparna.Roy@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-04 21:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Adds details from the report in paragraphs 3 and 4)      Oct 4 (Reuters) - GSK   , Sanofi    and CSL Ltd    have secured $72 million from the U.S. government to ramp up production of bird flu ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2472895499","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472895499","pubTimestamp":1728048304,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"(Adds details from the report in paragraphs 3 and 4)      Oct 4 (Reuters) - GSK   , Sanofi    and CSL Ltd    have secured $72 million from the U.S. government to ramp up production of bird flu vaccine","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","BK7067":"生物科技","BK7511":"ESG概念","BK7501":"新冠治疗股","CSL.AU":"CSL LIMITED"},"translate_title":"更新1-据彭博新闻报道，赛诺菲、葛兰素史克、CSL将扩大美国禽流感疫苗供应","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CSL.AU":1},"content_text":"(Adds details from the report in paragraphs 3 and 4)      Oct 4 (Reuters) - GSK   , Sanofi    and CSL Ltd    have secured $72 million from the U.S. government to ramp up production of bird flu vaccines, Bloomberg News reported on Friday.       The move comes as a multi-state outbreak among livestock and poultry has caused several human infections, raising concerns about further spread.   The companies will use the funds to fill vials and pre-filled syringes with stockpiled vaccine ingredients, aimed at raising the country's total supply of ready-to-use doses to 10 million within the first quarter of 2025, Dawn O'Connell, assistant secretary for preparedness and response at the U.S. Department of Health and Human Services told Bloomberg News.       The latest award from the government, which includes $37.9 million for CSL, $23.4 million for Sanofi and $10.5 million for GSK, would more than double the United States' supply of shots targeting bird flu, the report added.       The Department of Health and Human Services, Sanofi, CSL and GSK did not immediately respond to a Reuters request for comment. (Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas)((Sriparna.Roy@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2472895499"}